Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinopharm Tech HoldingsHKSE:08156 -2.50%27 Quick Ratio is 0.60 as of Dec. 2025, which is 173% above its 10-year median of 0.22. GuruFocus rates HKSE:08156 with a GF Score™ of 27/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 2,875 Software companies, Sinopharm Tech Holdings ranks worse than 89.36% on this metric.
Sinopharm Tech Holdings (HKSE:08156) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Sinopharm Tech Holdings Quick Ratio Related Terms
Sinopharm Tech Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08156 vs QH, SHOP, UBER: Quick Ratio Comparison
For the Software - Application subindustry, Sinopharm Tech Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Tech Holdings Quick Ratio vs Software Industry
For the Software industry and Technology sector, Sinopharm Tech Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Sinopharm Tech Holdings's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Sinopharm Tech Holdings's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Tech Holdings (HKSE:08156) has a Quick Ratio of 0.60 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sinopharm Tech Holdings and its competitors. This is 173% above median its historical median of 0.22. Over the past decade, Sinopharm Tech Holdings' Quick Ratio has ranged from 0.11 to 0.99. According to the industry distribution chart, Sinopharm Tech Holdings ranks #2569 out of 2875 companies in the Software industry, placing it in the top 89.4%.
Is Sinopharm Tech Holdings' Quick Ratio too high?
Sinopharm Tech Holdings' current Quick Ratio of 0.60 is 173% above median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.99. The Software industry median Quick Ratio is 1.68. Sinopharm Tech Holdings' value of 0.60 is 64.3% below this industry median. Based on the distribution chart, Sinopharm Tech Holdings ranks #2569 out of 2875 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Sinopharm Tech Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Tech Holdings' Quick Ratio compare to QH and SHOP?
According to the Software industry distribution chart, Sinopharm Tech Holdings ranks #2569 out of 2875 companies for Quick Ratio. This places Sinopharm Tech Holdings in the lower half of its industry. The industry median Quick Ratio is 1.68. Sinopharm Tech Holdings' value of 0.60 is 64.3% below this benchmark. Historically, Sinopharm Tech Holdings' own Quick Ratio has ranged from 0.11 to 0.99 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 1.68, Sinopharm Tech Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Software company?
The median Quick Ratio among Software companies is 1.68, based on 2,875 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Tech Holdings's current Quick Ratio of 0.60 is 64.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sinopharm Tech Holdings and its competitors. For the Software industry, the median Quick Ratio is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Tech Holdings's current Quick Ratio is 0.60, which is 173% above median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Tech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Tech Holdings (HKSE:08156) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.16 — trading 160% above its estimated fair value. The current Quick Ratio is 0.60, which is 173% above median its 10-year median of 0.22 and 64.3% below the Software industry median of 1.68. Sinopharm Tech Holdings' overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sinopharm Tech Holdings (HKSE:08156), the current Quick Ratio is 0.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued.
The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:08156:
Quick Ratio: 0.60 (173% above median its 10-year median of 0.22)
GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
Industry Position: 64.3% below the Software median (#2569 of 2875)
No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score
Get the complete analysis for HKSE:08156
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08156 has been successfully added to your 
